Your browser doesn't support javascript.
loading
Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.
Edahiro, Ryuya; Shiroyama, Takayuki; Hijiki, Sachiko; Nojima, Satoshi; Shirai, Yuya; Koyama, Shohei; Kumanogoh, Atsushi.
Afiliación
  • Edahiro R; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: takayuki.s12@hotmail.co.jp.
  • Hijiki S; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nojima S; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Shirai Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Koyama S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Lung Cancer ; 140: 116-117, 2020 02.
Article en En | MEDLINE | ID: mdl-31848027

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Escamosas / Linfocitos Infiltrantes de Tumor / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares / Miocarditis Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Escamosas / Linfocitos Infiltrantes de Tumor / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares / Miocarditis Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón